NYSE:NEUE NeueHealth (NEUE) Stock Price, News & Analysis → Log Into Marc's $5,000 System Today (From Chaikin Analytics) (Ad) Free neue Stock Alerts $5.98 +0.03 (+0.50%) (As of 05/28/2024 ET) Add Compare Share Share Today's Range$5.91▼$6.2350-Day Range$5.82▼$6.8052-Week Range$4.94▼$22.00Volume1,139 shsAverage Volume26,563 shsMarket Capitalization$49.18 millionP/E RatioN/ADividend YieldN/APrice Target$8.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Get NeueHealth alerts: Email Address NeueHealth MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside33.8% Upside$8.00 Price TargetShort InterestHealthy0.36% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 2 Articles This WeekInsider TradingSelling Shares$232,967 Sold Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.35 out of 5 starsMedical Sector620th out of 931 stocksHospital & Medical Service Plans Industry9th out of 12 stocks 3.0 Analyst's Opinion Consensus RatingNeueHealth has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageNeueHealth has only been the subject of 1 research reports in the past 90 days.Read more about NeueHealth's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.36% of the outstanding shares of NeueHealth have been sold short.Short Interest Ratio / Days to CoverNeueHealth has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NeueHealth has recently increased by 37.56%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldNeueHealth does not currently pay a dividend.Dividend GrowthNeueHealth does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NEUE. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 2 news articles for NeueHealth this week, compared to 2 articles on an average week.MarketBeat FollowsOnly 2 people have added NeueHealth to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, NeueHealth insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $232,967.00 in company stock.Percentage Held by Insiders64.30% of the stock of NeueHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions63.88% of the stock of NeueHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about NeueHealth's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of NeueHealth is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NeueHealth is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about NeueHealth's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself About NeueHealth Stock (NYSE:NEUE)NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.Read More NEUE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NEUE Stock News HeadlinesMay 23, 2024 | americanbankingnews.comHead to Head Analysis: NeueHealth (NYSE:NEUE) & Clover Health Investments (NASDAQ:CLOV)May 11, 2024 | msn.comNeueHealth, Inc. (NYSE:NEUE) Q1 2024 Earnings Call TranscriptMay 9, 2024 | finance.yahoo.comQ1 2024 NeueHealth Inc Earnings CallMay 9, 2024 | finance.yahoo.comNeueHealth Inc (NEUE) (Q1 2024) Earnings Call Transcript Highlights: Insights and Strategic ...May 8, 2024 | markets.businessinsider.comNeueHealth Q1 Revenue DropsMay 8, 2024 | msn.comNeueHealth GAAP EPS of -$2.31, revenue of $245.09MMay 8, 2024 | washingtonpost.comNeueHealth: Q1 Earnings SnapshotMay 8, 2024 | businesswire.comNeueHealth Reports First Quarter 2024 ResultsApril 18, 2024 | businesswire.comNeueHealth to Host First Quarter 2024 Earnings Conference Call on May 8, 2024April 12, 2024 | uk.investing.comNeueHealth executive Rick Yang acquires $4,949 in warrantsApril 12, 2024 | uk.investing.comNeueHealth insider acquires warrants valued at $4,949April 12, 2024 | investing.comNeueHealth insider acquires warrants worth $7,423April 12, 2024 | investing.comNeueHealth insider acquires warrants worth $3,711April 9, 2024 | businesswire.comNeueHealth Enters into Amendment to its Credit FacilityApril 1, 2024 | msn.comBright Health CEO's bonus grew to $1.95M amid slashed workforceMarch 22, 2024 | investing.comNeueHealth CFO sells over $7,800 in company stockMarch 22, 2024 | investing.comNeueHealth CEO sells shares worth over $36kMarch 20, 2024 | investing.comNeueHealth CEO sells over $41k in company stockMarch 20, 2024 | investing.comNeueHealth executive sells over $1800 in stock to cover tax obligationsMarch 6, 2024 | businesswire.comNeueHealth Reports Fourth Quarter and Full Year 2023 ResultsFebruary 20, 2024 | businesswire.comNeueHealth to Host Fourth Quarter 2023 Earnings Conference Call on March 6, 2024See More Headlines Receive NEUE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeueHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/08/2024Today5/28/2024Next Earnings (Estimated)8/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Hospital & medical service plans Sub-IndustryN/A Current SymbolNYSE:NEUE Previous SymbolNYSE:NEUE CUSIPN/A CIK1671284 Webwww.brighthealthgroup.com Phone612-238-1321FaxN/AEmployees1,252Year FoundedN/APrice Target and Rating Average Stock Price Target$8.00 High Stock Price Target$8.00 Low Stock Price Target$8.00 Potential Upside/Downside+33.8%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($130.73) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,151,450,000.00 Net Margins-89.78% Pretax Margin-51.58% Return on Equity-5.62% Return on Assets2.57% Debt Debt-to-Equity RatioN/A Current Ratio0.77 Quick Ratio0.77 Sales & Book Value Annual Sales$1.11 billion Price / Sales0.04 Cash Flow$66.44 per share Price / Cash Flow0.09 Book Value($158.35) per share Price / Book-0.04Miscellaneous Outstanding Shares8,224,000Free Float2,936,000Market Cap$49.18 million OptionableN/A Beta0.78 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Robert John Sheehy (Age 66)Co-Founder & Chairman Mr. George Lawrence Mikan III (Age 52)Vice Chairman, CEO & President Comp: $3.52MMr. Jay Stephen Matushak (Age 49)Chief Financial Officer Comp: $950.28kMr. Tomas Orozco (Age 48)Executive Vice President of Consumer Care Comp: $1.14MMr. Jeffrey Joseph SchermanChief Accounting OfficerMr. Jeff Craig (Age 41)General Counsel & Corporate Secretary Comp: $582.55kMs. Stacy ContiChief People OfficerMs. Megan NorthPresident of NeueSolutionsMr. Joaquin Baralt M.D.President of Value-Based CareMore ExecutivesKey CompetitorsBright Health GroupNYSE:BHGUnitedHealth GroupNYSE:UNHElevance HealthNYSE:ELVThe Cigna GroupNYSE:CIHumanaNYSE:HUMView All CompetitorsInsidersJay MatushakSold 317 sharesTotal: $1,917.85 ($6.05/share)Jeffrey J SchermanSold 113 sharesTotal: $683.65 ($6.05/share)George Lawrence Mikan IIISold 4,990 sharesTotal: $36,277.30 ($7.27/share)Jay MatushakSold 1,083 sharesTotal: $7,873.41 ($7.27/share)Tomas OrozcoSold 822 sharesTotal: $5,975.94 ($7.27/share)View All Insider Transactions NEUE Stock Analysis - Frequently Asked Questions Should I buy or sell NeueHealth stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for NeueHealth in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" NEUE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NEUE, but not buy additional shares or sell existing shares. View NEUE analyst ratings or view top-rated stocks. What is NeueHealth's stock price target for 2024? 1 Wall Street research analysts have issued 1-year price targets for NeueHealth's stock. Their NEUE share price targets range from $8.00 to $8.00. On average, they predict the company's stock price to reach $8.00 in the next twelve months. This suggests a possible upside of 33.8% from the stock's current price. View analysts price targets for NEUE or view top-rated stocks among Wall Street analysts. How have NEUE shares performed in 2024? NeueHealth's stock was trading at $6.53 at the beginning of the year. Since then, NEUE stock has decreased by 8.4% and is now trading at $5.98. View the best growth stocks for 2024 here. Are investors shorting NeueHealth? NeueHealth saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 29,300 shares, an increase of 37.6% from the April 30th total of 21,300 shares. Based on an average trading volume of 11,800 shares, the days-to-cover ratio is presently 2.5 days. View NeueHealth's Short Interest. When is NeueHealth's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024. View our NEUE earnings forecast. How were NeueHealth's earnings last quarter? NeueHealth, Inc. (NYSE:NEUE) posted its quarterly earnings results on Wednesday, May, 8th. The company reported ($2.31) earnings per share (EPS) for the quarter. The firm had revenue of $245.10 million for the quarter. NeueHealth had a negative net margin of 89.78% and a negative trailing twelve-month return on equity of 5.62%. How do I buy shares of NeueHealth? Shares of NEUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:NEUE) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsBitcoin’s Biggest Year YetParadigm PressThe #1 Crypto for AIWeiss RatingsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesElon’s New Device is About to Shock the WorldInvestorPlaceHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeueHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
